Proto Labs Reports Officer/Director Changes & Financials
Ticker: PRLB · Form: 8-K · Filed: Oct 7, 2024 · CIK: 1443669
| Field | Detail |
|---|---|
| Company | Proto Labs Inc (PRLB) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-changes, director-changes, financials
TL;DR
Proto Labs filed an 8-K for 10/1, reporting leadership changes and financial docs.
AI Summary
Proto Labs, Inc. filed an 8-K on October 7, 2024, reporting events as of October 1, 2024. The filing indicates changes related to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This filing signals potential shifts in company leadership and governance, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors or officers can indicate internal shifts that may affect company strategy or performance.
Key Players & Entities
- Proto Labs, Inc. (company) — Registrant
- October 1, 2024 (date) — Earliest event reported
- October 7, 2024 (date) — Date of report
FAQ
What specific officer or director positions were affected by the changes reported on October 1, 2024?
The filing indicates changes related to the departure of directors or certain officers, election of directors, and appointment of certain officers, but does not specify the exact positions in the provided text.
Are the compensatory arrangements mentioned related to new appointments or existing officers?
The filing states 'Compensatory Arrangements of Certain Officers' as an item information, but the specific details regarding whether these are for new or existing officers are not provided in this excerpt.
What types of financial statements and exhibits are included in this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific content of these documents is not detailed in the provided text.
What is the principal executive office address for Proto Labs, Inc.?
The principal executive offices are located at 5540 Pioneer Creek Drive, Maple Plain, Minnesota 55359.
What is the filing date of this Form 8-K?
This Form 8-K was filed on October 7, 2024.
Filing Stats: 871 words · 3 min read · ~3 pages · Grade level 11.8 · Accepted 2024-10-07 06:04:04
Key Financial Figures
- $0.001 — ich registered Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchange
Filing Documents
- prlb-20241001.htm (8-K) — 32KB
- prlb-202410x07xexx101.htm (EX-10.1) — 58KB
- 0001628280-24-042356.txt ( ) — 221KB
- prlb-20241001.xsd (EX-101.SCH) — 2KB
- prlb-20241001_lab.xml (EX-101.LAB) — 21KB
- prlb-20241001_pre.xml (EX-101.PRE) — 12KB
- prlb-20241001_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Settlement Agreement, fully executed on October 1, 2024 between Proto Labs, Inc., Proto Labs Germany GmbH and Bjoern Klaas 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Proto Labs, Inc. Date: October 7, 2024 By: /s/ Robert Bodor Robert Bodor President and Chief Executive Officer